PALO ALTO, Calif.– The Gordon and Betty Moore Foundation today announced the election of a new trustee, Pardis Sabeti, M.D., DPhil. A distinguished geneticist and professor, Dr. Sabeti is known for her innovative research in infectious disease genomics and her pioneering role in developing rapid diagnostic tools for epidemic outbreaks.
“It’s an absolute honor to join the Gordon and Betty Moore Foundation. I am deeply inspired by their vision to drive meaningful change in science, the environment, and local communities, and by their commitment to shaping a better future for all,” said Dr. Sabeti. “This work is vital in today’s world, and I look forward to doing everything in my power to help advance the Moore mission.”
Dr. Sabeti is a core institute member of the Broad Institute of MIT and Harvard and a leader in the Broad’s Infectious Disease and Microbiome Program. She also holds appointments as professor at the Center for Systems Biology and the Department of Organismic and Evolutionary Biology at Harvard University, a professor in the Department of Immunology and Infectious Disease at Harvard T.H. Chan School of Public Health, and as a Howard Hughes Medical Institute investigator.
Her lab focuses on understanding genetic responses to pathogens and has contributed significantly to combating diseases like Ebola through genomic sequencing and data-driven approaches.
Beyond research, Sabeti is deeply involved in initiatives aimed at pandemic preparedness, including creating Operation Outbreak, founding SHERLOCK Biosciences and leading projects to enhance global health responses. Her achievements have earned her recognition, including being named a TIME “Person of the Year.”
“By virtue of her expertise, her achievements, and her leadership, Pardis Sabeti is an ideal addition to our Board of Trustees,” said Harvey V. Fineberg, M.D., Ph.D., president of the foundation. “Her advances in computational genetics, collaborative success in establishing counterpart labs, and commitment to informal science education in the context of pandemics will bring added value to our work.”
